Mojtahed SA, Boyer NR, Rao SA, Gajewski TF, et al. ASO Visual Abstract: Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage 3 Melanoma in Medicare Patients. Ann Surg Oncol 2021 Aug 5. pii: 10.1245/s10434-021-10345.
PMID: 34355335